Research Analysts’ New Coverage for May 11th (ARXS, BMRN, GENI, KLAR, LOKV, MAIR, OKLO, SANA, URGN)

Research Analysts’ new coverage for Monday, May 11th:

Melius Research assumed coverage on shares of Arxis (NASDAQ:ARXS). The firm issued a buy rating and a $45.00 target price on the stock.

The Goldman Sachs Group, Inc. assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). The firm issued a neutral rating and a $69.00 price target on the stock.

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genius Sports (NYSE:GENI). The firm issued a buy rating and a $10.00 price target on the stock.

TD Cowen began coverage on shares of Klarna Group (NYSE:KLAR). The firm issued a hold rating and a $16.00 price target on the stock.

Compass Point initiated coverage on shares of Live Oak Acquisition (NASDAQ:LOKV). Compass Point issued a buy rating and a $13.50 price target on the stock.

Vertical Research began coverage on shares of Madison Air Solutions (NYSE:MAIR). Vertical Research issued a buy rating and a $50.00 price target on the stock.

William Blair assumed coverage on shares of Madison Air Solutions (NYSE:MAIR). The firm issued an outperform rating on the stock.

Bank of America Corporation assumed coverage on shares of Madison Air Solutions (NYSE:MAIR). They issued a buy rating and a $47.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of Oklo (NYSE:OKLO). They issued a neutral rating and a $83.00 price target on the stock.

Rodman & Renshaw assumed coverage on shares of Sana Biotechnology (NASDAQ:SANA). The firm issued a buy rating and a $16.00 target price on the stock.

LADENBURG THALM/SH SH initiated coverage on shares of Urogen Pharma (NASDAQ:URGN). The firm issued a buy rating and a $43.00 price target on the stock.